The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney disease
Open accessAbstract
During chronic kidney disease (CKD), alterations in bone and mineral metabolism include increased production of the hormone fibroblast growth factor 23 (FGF23) that may contribute to cardiovascular mortality. The osteocyte protein dentin matrix protein 1 (DMP1) reduces FGF23 and enhances bone mineralization, but its effects in CKD are unknown. We tested the hypothesis that DMP1 supplementation in CKD would improve bone health, prevent FGF23 elevations and minimize consequent adverse cardiovascular outcomes. We investigated DMP1 regulation and effects in wild-type (WT) mice and the Col4a3−/− mouse model of CKD. Col4a3−/− mice demonstrated impaired kidney function, reduced bone DMP1 expression, reduced bone mass, altered osteocyte morphology and connectivity, increased osteocyte apoptosis, increased serum FGF23, hyperphosphatemia, left ventricular hypertrophy (LVH), and reduced survival. Genetic or pharmacological supplementation of DMP1 in Col4a3−/− mice prevented osteocyte apoptosis, preserved osteocyte networks, corrected bone mass, partially lowered FGF23 levels by attenuating NFAT-induced FGF23 transcription, and further increased serum phosphate. Despite impaired kidney function and worsened hyperphosphatemia, DMP1 prevented development of LVH and improved Col4a3−/− survival. Our data suggest that CKD reduces DMP1 expression, whereas its restoration represents a potential therapeutic approach to lower FGF23 and improve bone and cardiac health in CKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




![Fig. 5 DMP1 inhibits FGF23 transcription through regulation of NFAT1 signaling. a, b Serum levels of total FGF23 (cFGF23) in B6 WT and DMP1TG mice 6 h after saline, calcium chloride (3%) and/or NFAT inhibitor (10 µg·g–1) treatment. c FGF23 mRNA expression in untreated and calcium-treated (12 mmol·L–1) primary osteoblasts (BMSCs) isolated from B6 WT and DMP1TG mice. d, e FGF23 promoter activity in MC3T3-E1 osteoblasts transfected with an intact (p[FGF23WT/Luc]) or NFAT mutant (p[FGF23NFAT/Luc]) FGF23 promoter reporter and treated with mouse recombinant DMP1, calcium and/or NFAT inhibitor. f NFAT1 mRNA expression in cortical bone of B6 WT, DMP1TG, Col4a3−/−, and Col4a3−/−/DMP1TG mice. Values are expressed as mean ± SEM; n ≥ 5/group. P < 0.05 vs. a WT or control, b Col4a3−/− or calcium (3% and 6 mmol·L–1), c calcium (12 mmol·L–1), d calcium (12 mmol·L–1) + DMP1 (10 ng·mL–1), e calcium (12 mmol·L–1) + NFAT inhibitor (1 µg·mL–1)](https://figures.cochat.ai/paper-figures/967dc301ce3d4669ae8d51778e48dda6/dmp1-prevents-osteocyte-alterations-fgf23-elevation-and-left-ventricular-figure-5.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In addition, findings in an experimental mouse model of chronic kidney J o u r n a l P r e -p r o o f disease demonstrated that restoring DMP1 protects against the development of cardiovascular disease and improves survival 43 .”
From Sex-specific gene expression signatures of calcific aortic valve stenosis in a large collection of human tissues (2026) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
FGF23 induces left ventricular hypertrophy
Faul, C., Amaral, A. P., Oskouei, B., Hu, M.-C., Sloan, A., Isakova, T., Gutiérrez, O. M., Aguillon-Prada, R., Lincoln, J., Hare, J. M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46122 · Cited by 2,027
Self-citationFGF-23 Is a Potent Regulator of Vitamin D Metabolism and Phosphate Homeostasis
Shimada, T., Hasegawa, H., Yamazaki, Y., Muto, T., Hino, R., Takeuchi, Y., Fujita, T., Nakahara, K., Fukumoto, S., & Yamashita, T. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0301264 · Cited by 1,883
Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
Gutiérrez, O. M., Mannstadt, M., Isakova, T., Rauh-Hain, J. A., Tamez, H., Shah, A., Smith, K., Lee, H., Thadhani, R., Jüppner, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706130 · Cited by 1,727
Self-citationShimada, T., Kakitani, M., Yamazaki, Y., Hasegawa, H., Takeuchi, Y., Fujita, T., Fukumoto, S., Tomizuka, K., & Yamashita, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19081 · Cited by 1,596
Shimada, T., Kakitani, M., Yamazaki, Y., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200419081 · Cited by 1,368
Isakova, T., on behalf of the Chronic Renal Insufficiency Cohort (CRIC) Study Group, Wahl, P., Vargas, G. S., Gutiérrez, O. M., Scialla, J., Xie, H., Appleby, D., Nessel, L., Bellovich, K., et al. (2011) · Kidney International · doi:10.1038/ki.2011.47 · Cited by 1,266
Self-citationFeng, J. Q., Ward, L. M., Liu, S., Lu, Y., Xie, Y., Yuan, B., Yu, X., Rauch, F., Davis, S. I., Zhang, S., et al. (2006) · Nature Genetics · doi:10.1038/ng1905 · Cited by 1,199
Self-citationIsakova, T. (2011) · JAMA · doi:10.1001/jama.2011.826 · Cited by 1,020
Self-citationFibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
Gutiérrez, O. M., Januzzi, J. L., Isakova, T., Laliberte, K., Smith, K., Collerone, G., Sarwar, A., Hoffmann, U., Coglianese, E., Christenson, R., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.844506 · Cited by 837
Self-citation
Research works printed but not linked: 1
- Neuburg, S. et al. Genetic background influences cardiac phenotype in murine chronic kidney disease. Nephrol. Dial. Transplant. 33, 1129–1137 (2018). · DOI
Cited by
The Bone Extracellular Matrix in Bone Formation and Regeneration
Lin, X., Patil, S., Gao, Y.-G., & Qian, A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00757 · Cited by 762
Marcucci, G., Domazetovic, V., Nediani, C., Ruzzolini, J., Favre, C., & Brandi, M. L. (2023) · Antioxidants · doi:10.3390/antiox12020373 · Cited by 175
The Mechanosensory Role of Osteocytes and Implications for Bone Health and Disease States
Choi, J. U. A., Kijas, A. W., Lauko, J., & Rowan, A. E. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.770143 · Cited by 157
The roles of osteocytes in alveolar bone destruction in periodontitis
Huang, X., Xie, M., Xie, Y., Feng, M., Lu, X., Li, X., & Chen, L. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02664-7 · Cited by 134
Calciprotein particles regulate fibroblast growth factor-23 expression in osteoblasts
Akiyama, K., Miura, Y., Hayashi, H., Sakata, A., Matsumura, Y., Kojima, M., Tsuchiya, K., Nitta, K., Shiizaki, K., Kurosu, H., et al. (2019) · Kidney International · doi:10.1016/j.kint.2019.10.019 · Cited by 116
Metadata
- Authors
- Dussold, C., Gerber, C., White, S., Wang, X., Qi, L., Francis, C., Capella, M., Courbon, G., Wang, J., Li, C., Feng, J. Q., Isakova, T., Wolf, M., David, V., & Martin, A.
- Affiliations
- Northwestern University (US)
- Texas A&M University (US)
- Duke University (US)
- Corresponding author
- Martin, Aline
- ORCID
- Venue
- Bone Research
- Published
- 2019-04-25
- Volume
- 7
- Issue
- 1
- Pages
- 12-12
- ISSN
- 2095-4700 (ISSN-L)
- 2095-6231
- PMC
- PMC6483996
- OpenAlex
- W2941262857
- Cited by
- 96
- References
- 47
- Citations by year
- 2026: 16 · 2025: 13 · 2024: 11 · 2023: 15 · 2022: 12 · 2021: 14 · 2020: 10 · 2019: 5
- FWCI
- 7.92
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Bone Research (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01DK101730, R01DK076116, R01DK102815)
- Topics
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Keywords
- DMP1, chronic kidney disease, fibroblast growth factor 23, osteocytes, left ventricular hypertrophy, Col4a3 knockout mice, osteocyte apoptosis, bone mineralization, hyperphosphatemia, cardiovascular mortality, bone health
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney disease. https://app.cochat.ai/papers/10.1038/s41413-019-0051-1
- The paper
- Dussold, C., Gerber, C., White, S., Wang, X., Qi, L., Francis, C., Capella, M., Courbon, G., Wang, J., Li, C., Feng, J. Q., Isakova, T., Wolf, M., David, V., & Martin, A. (2019). DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney disease. Bone Research. https://doi.org/10.1038/s41413-019-0051-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.